Psychology Shelf Flashcards
Antidepressants
Tricyclic and heterocyclins SSRI/SSNRI/MAOI
Tricyclics and Heterocyclics
MOA Increase the level of monoamines in the synapse by reducing the reuptake of norepineprine and serotonin. Warning narrow therapeutic window, overdose causes fatal arrhytmias
SSRI and SSNRI
Most commonly used antidepressants today. Major side effects: GI disturbances and sexual dysfunction
MAOI
More helpful in depression with atypical features. Not commmonly used bc a tyramine-free diet (no red wine or aged cheese) must be followed or a hypertensive crisis can results
Lithium (side Effects)
Tremor, polyuria/diabetes insipidus, acne, hypothyroidism, cardia dysrhythmias, weight gain, edema, leukocytosis. * cleared through kidney*
Valproic acid (warning
Teratogenic
1st generation antipsychotics (typical)
MOA: block central dopamine receptors. Most effective in reducing the positive symptoms of schizophrenia (ex. Hallucinations and delusions)
Tricyclics and Tetracyclics (side effects)
Anticholinergic: dry mouth, blurry vision, urinary retention, constipation, sedation, orthostatic hypotension (alpha blocaked), tachycardia, prolonged QT, weight gain. Fall risk in elederly. Half life: 6-30 h.
Amitriptyline
Tertiary amine. Highly anticholinergic, very sedating. Half life 20 h
Doxepin
Tertiary amine. Highly anticholinergic, very sedating. Half life 16 h
imipramine
tertiary amine. Highly anticholinergic. Half life 20 h
Clomipramine
Tertiary amine. Anticholinergic, sedating, OCD responds well, useful in patients with depression w/marked obsessive features. Half life 21 h
Trimipramine
tertiary amine. Highly anticholinergic, very sedating. Half life 22 h
Desipramine
secondary amine. Least anticholinergic, not sedating. Half life 24 h
Nortriptyline
secondary amine less anticholinergic, half life 12 h
Protriptyline
secondary amine less anticholinergic, not sedating. half life 6 h
Amoxapine
tetracyclic. May cause EPS and NMS. (metabolite of loxapine). Less anticholinergic. Half life 30 h
SSRI and SSNRI (side effects)
Agitation, akathisia, anxiety, panic, insomnia, diarrhea, GI distress, headache, sexual dysfunction. To avoid fata serotonin syndrome no SSRI or SSNRI should be combined with a MAOI and an SSRI should be stopped at least 5 weeks before starting an MAOI
Fluoxetine
SSRI. Used in OCD. Half life 1-3 days
Sertraline
SSRI, causes diarrhea more than others. Used in OCD. Half life 25 h
Paroxetine
SSRI. Mildly anticholinergic. Used in treatment of OCD. Half life 24 h
Fluvoxamine
SSRI. Naused and vomiting more common. Used in OCD. Half life 15 h
Citalopram
SSRI. Possibly fewer sexual side effects. Half life 35 h
Escitalopram
SSRI. Half life 27- 30 h
Venlafaxine
SE: anxiety, may increase BP at highter dose, headache, insomnia, sweating. SNRI, used to treat GAD and social anxiety. Half life 3.5 h. active metabolite 9 h
Duloxetine
SSNRI. Used to treat GAD and painful diabetic neuropathy. Half life 12 h
Phenelzine
SE: orthostatic hypotension, somnolense, weight gain. Half life 4-5 h. MAOI
Isocarboxazid
MAOI. Orthostatic hypotension, somnolence, weight gain. Half life 2.5 h
Selegiline
MAOI. Orthostatic hypotension, weight gain somnolence, irritation at patch site. Transdermal delivered, treats depression and parkinsonism. Half life of 2 h
Tranylcypromine
MAOI. Orthostatic hypotension, somnolence, weight gain. Half life 2-3 h
Nefazodone
MOA: Serotonin-2 antagonist and serotonin reuptake inhibitor. SE: sedation hepatotoxicity. Less sexual dysfunction. Half life 2 - 4 h.
Trazodone
MOA: Serotonin-2 antagonist and serotonin reuptake inhibitor. SE: priapism, orthostatic hypotension, sedation. Sleep problems at lower doses
Mirtazapine
MOA: noradrenergic and specific serotonin antagonist. SE: weight gain, sedation. No sexual dysfunction, nausea or diarrhea. Half life of 20-40 h
Buproprion
MOA: norepinephrine and dopamine reuptake inhibitor. SE: nausea, anorexia, risk of seizures at higher doses, less sexual dysfunction. Used for smoking cessation. Half life 14 h.
Lithium
MOA: inhibits adenylate cyclase enzyme. SE: nause, tremor, hypothyroidism, dysrhythmias, diarrhea, diabetes insipidus. At toxic levels significant alterations in consciousness, seizures coma and death.
Valproic acid, valproate
MOA: opens chloride channels. SE: thrombocytopenia, weight gain, pancreatitis, hair loss, GI distress, cognitive dulling, neural tube defects in pregnancy
Divalproex sodium
MOA: opens chloride channels. SE: thrombocytopenia, pancreatitis, weight gain, hair loss GI distress, cognitive dulling, neural tube defects in pregnancy
Carbamazepine
MOA: inhibits kindling, inhibits reptitive firing action potentials by inactivating sodium channels. SE: agranulocytosis, nausea, vomiting, slurred speech, dizziness, drowsiness, high liver function tests, congitive slowing, may cause craniofacial defects in newborn. Potent inducer of P450
Lamotrigine
May have acute antidepressant effect. Dose may be increased slowly to avoid rash. SE: leukopenia, rash, hepatic failure, nausea, vomiting, diarrhea, somnolence, dizziness
Gabapentin
SE: somnolence, dizziness, ataxia, fatigue, leukopenia, weight gain. No drug interactions. Rash can be fatal.
Topiramate
SE: psychomoto slowing, memory problems, fatique. Many drug-drug interactions
Chlorpromazine
1st generation antipsychotic. Potency=low. Sedation and orthostatic hypotension are very common
Haloperidol
1st generation antipsychotic. Potency=high. EPS very common: available in long acting intramuscular depot
Thioridazine
1st generation antipsychotic. Potency low. Higher incidence of cardia disturbances, retinitis pigmentosum
Mesoridazine
1st generation antipsychotic. Potency low. Torsades de pointes
Molindone
1st generation antipsychotic. Potency medium
Fluphenazine
1st generation antipsychotic. Potency high. Available in a long acting intramuscular depot
Trifluoperazine
1st generation antipsychotic. High potency.
Thiothixene
1st generation antipsychotic. High potency.
Perphenazine
1st generation antipsychotic. High potency.
Loxapine
1st generation antipsychotic. Medium potency.
Pimozide
1st generation antipsychotic. High potency.
Aripiprazole
MOA: partial agonist ast dopamine and serotonin-1A recptors and antagonist at postsynaptic serotonin-2A receptors. SE: heatahe, nausea, anxiety, insomnia, somnolnce. 2nd generation antipsychotic
Ziprasidone
MOA: serotonin-dopamine antagonist. SE: dose-related QT prolongation, postural hypotension, sedation. Present in breast milk. 2nd generation antipsychotic
Quetiapine
MOA: serotonin-dopamine antagonist. SE: orthostatic hypotension, transient Increase in weight, somnolence. Risk of developing cataracts. 2nd generation antypsychotic
Olanzapine
MOA: serontonin-dopamine antagonist. SE: Inc. prolactin, orthostatic hypotension, anticholinergic side effects, weight gain, somnolence. 2nd generation antipsychotic
Risperidone
MOA: serontonin-dopamine antagonist. SE: extrapyramidal withdrawal syndrome in high doses, postural hypotension, increased prolactin, weight gain, sedation, decrease concentration. Present in breast milk. 2nd generation antipsychotic
Clozapine
MOA: serotonin-dopamine antagonist. SE: agranulocytosis, anticholinergic side effects, weight gain, sedation, neuroleptic malignant syndrome. 2nd generation antipsychotic
Buspirone
Indication: GAD. SE: headache, GI distress, dizziness. Do not use with MAOI
Zolpidem
Indication: Insomnia. SE: headache, drowsiness, dizziness, nausea, diarrhea. Inc. effect with alcohol or SSRI
Zaleplon
Indication: Insomnia. SE: headache, peripheral edema, amnesia, dizziness, rash, nausea, tremor
Ramelteon
Indication: Insomnia. SE: headache, galactorrhea. Melatonin receptor agonist, no affinity for GABA receptor complex
Eszopilone
Indication: Insomnia. SE: anxiety, dec. sexual desire, dry mouth, unpleasant taste. Stopping this drug suddenly can cause anxiety, unusual dreams, stomach and muscle cramps, nausea, vomiting, sweating and shakiness
Dextroamphetamine and Amphetamine
Stimulant. Treats ADHD. SE: nervousness, restlessness + difficulty falling asleep or staying asleep. May slow kids growth/weight gain; may be addictive
Modafinil
Stimulant. Treats Narcolepsy, excessive daytime sleepiness. SE: dizziness, insomnia, diarrhea. Increase release of monoamines and increase hypothalamic histamine levels
Dextroamphetamine
Stimulant. Treats ADHD and Narcolepsy. SE: nervousness, restlessness, and difficulty falling/staying asleep. May be addictive
Methylphenidate
Stimulant. Treats ADHE and Narcolepsy. SE: nervousness, restlessness, difficulty falling/staying asleep
Alloplastic Defenses
Defenses used by patients who react to stress by attempting to change the external environment by threatening or manipulating others
Autoplastic Defenses
Defenses used by patients who react to stress by changing their internal psychological process
Ego-Dystonic
Describes a character deficit perceived by a patient as objectionable, distressing, or inconsistent to the selft
Ego-Syntonic
Describes a character deficit perceived by the aptient to be acceptable, unobjectable and consistent to the self. The patient tends to blame others for problems that occur
Schizoid
Loner. Detacher. Flat affect. Restricted emotions. Generally indifferent to interpersonal relationships outside of immediate family.
Schizotypal
Odd. Eccentric. Magical thinking. Paranoid. Not psychotic
Paranoid
Distrustful. Suspicious. Constricted affect
Histrionic
Excessively emotional. Attention seeking
Narcissistic
Self-important. Needs admiration. Dismissive of the feelings of others